These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9870462)

  • 21. Transmission routes of HCV infection in dialysis.
    Jadoul M
    Nephrol Dial Transplant; 1996; 11 Suppl 4():36-8. PubMed ID: 8918750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of nosocomial transmission of hepatitis C infection in a hemodialysis unit. A prospective study.
    Djordjević V; Stojanović K; Stojanović M; Stefanović V
    Int J Artif Organs; 2000 Mar; 23(3):181-8. PubMed ID: 10795663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C infection among dialysis patients: a comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis.
    Chan TM; Lok AS; Cheng IK
    Nephrol Dial Transplant; 1991; 6(12):944-7. PubMed ID: 1724691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus infection in renal dialysis patients in Glasgow.
    McIntyre PG; McCruden EA; Dow BC; Cameron SO; McMillan MA; Allison ME; Briggs JD
    Nephrol Dial Transplant; 1994; 9(3):291-5. PubMed ID: 7519762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C in hemodialysis: epidemiology and prevention of hepatitis C virus transmission.
    Jadoul M; Barril G
    Contrib Nephrol; 2012; 176():35-41. PubMed ID: 22310779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Large Outbreak of Hepatitis C Virus Infections in a Hemodialysis Clinic.
    Nguyen DB; Gutowski J; Ghiselli M; Cheng T; Bel Hamdounia S; Suryaprasad A; Xu F; Moulton-Meissner H; Hayden T; Forbi JC; Xia GL; Arduino MJ; Patel A; Patel PR
    Infect Control Hosp Epidemiol; 2016 Feb; 37(2):125-33. PubMed ID: 26573412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of a national epidemiological investigation of HCV infection in dialysis patients.
    Lombardi M; Cerrai T; Geatti S; Negroni S; Pertusini L; Pegoraro M; Di Lullo G
    EDTNA ERCA J; 1999; 25(3):38-42. PubMed ID: 10786494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Control of HCV, HBV and HIV Infections in Hemodialysis].
    Fabrizi F; Martin P; Messa P
    G Ital Nefrol; 2013; 30(4):. PubMed ID: 24403201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatitis C virus and chronic progressive kidney disease].
    Kes P; Slavicek J
    Acta Med Croatica; 2009 Dec; 63(5):431-6. PubMed ID: 20198903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus screening and management of seroconversions in hemodialysis facilities.
    Mbaeyi C; Thompson ND
    Semin Dial; 2013; 26(4):439-46. PubMed ID: 23859188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low seroconversion for hepatitis C virus (HCV) antibody achieved by universal precautions alone.
    Flett A; Teo M; Mah YI; Mortlock F; Choo BB; Challinor SP; Woods HF
    EDTNA ERCA J; 1998; 24(2):40-2. PubMed ID: 10392065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis and transfusions.
    Donnelly K
    Nephrol Nurs J; 2000 Oct; 27(5):538-9. PubMed ID: 16649331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus in the hemodialysis setting: detecting viral RNA from blood port caps by reverse transcription-polymerase chain reaction.
    Hardy NM; Chiao J; Arora N; Mars R; Jenkins SG
    Clin Nephrol; 2000 Aug; 54(2):143-6. PubMed ID: 10968691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hand contamination with hepatitis C virus in staff looking after hepatitis C-positive hemodialysis patients.
    Alfurayh O; Sabeel A; Al Ahdal MN; Almeshari K; Kessie G; Hamid M; Dela Cruz DM
    Am J Nephrol; 2000; 20(2):103-6. PubMed ID: 10773609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hepatitis C virus infection in hemodialysis].
    Simon N
    Pathol Biol (Paris); 1995 Oct; 43(8):735-40. PubMed ID: 8745596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for HCV infection in two haemodialysis units in The Netherlands.
    Keur I; Schneeberger PM; van der Graaf Y; Vos J; van Dijk WC; van Doorn LJ
    Neth J Med; 1997 Mar; 50(3):97-101. PubMed ID: 9121598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The management of dialysis patients seropositive for HBsAg, anti-HCV, or anti-HIV antibodies].
    Fabrizi F; Messa P
    G Ital Nefrol; 2012; 29 Suppl 56():S78-84. PubMed ID: 23059944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 1990s perspective of hepatitis C, human immunodeficiency virus, and tuberculosis infections in dialysis patients.
    Murthy BV; Pereira BJ
    Semin Nephrol; 1997 Jul; 17(4):346-63. PubMed ID: 9241719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of hemodialysis machines dedication in reducing Hepatitis C transmission in the dialysis setting in Iran: a multicenter prospective interventional study.
    Shamshirsaz AA; Kamgar M; Bekheirnia MR; Ayazi F; Hashemi SR; Bouzari N; Habibzadeh MR; Pourzahedgilani N; Broumand V; Shamshirsaz AH; Moradi M; Borghei M; Haghighi NN; Broumand B
    BMC Nephrol; 2004 Oct; 5():13. PubMed ID: 15469615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.